These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The metabolism of radiolabelled GM1-ganglioside in cultured skin fibroblasts from controls and patients with GM1-gangliosidosis].
    Author: Inui K.
    Journal: Nihon Rinsho; 1995 Dec; 53(12):3102-4. PubMed ID: 8577066.
    Abstract:
    The metabolism of [3-3H-sphingosine] GM1-ganglioside was studied in cultured skin fibroblasts from control and patients with beta-galactosidase deficiency, primarily or secondarily. When dissolved in the medium with phosphatidylserine, GM1-ganglioside was efficiently taken up by cultured skin fibroblasts and transferred into lysosomes. A pulse-chase study revealed that [3-3H-sphingosine] GM1-ganglioside was metabolized to GM2-, GM3-ganglioside, ceramide, ceramide monohexoside, ceramide dihexoside and sphingomyelin. In a 20h pulse study, cell lines from patients with GM1-gangliosidosis of infantile, juvenile and adult types hydrolyzed 2 approximately 5%, 20 approximately 44% and 54 approximately 58% of the total endocytosed GM1-ganglioside respectively. These values were lower than in the control cells (62.2 +/- 5.43% (n=10). The hydrolysis rates of exogenous [3-3H-sphingosine] GM1-ganglioside in cultured skin fibroblasts from various types of GM1-gangliosidosis closely correlated to the clinical severity. This method is also useful to the diagnosis of impaired ganglioside metabolism.
    [Abstract] [Full Text] [Related] [New Search]